METHYLPREDNISOLONE ACETATE Recall D-1097-2022
Description: Depo-Medrol (methylprednisolone acetate injectable suspension, USP) 80mg/mL, packaged in a) 1 mL single-dose vial (NDC# 0009-3475-01), b) 25-count box (NDC 0009-3475-03), Rx only, MFG: Pfizer
METHYLPREDNISOLONE ACETATE Recall D-1097-2022 Information
Status | Ongoing |
Mandated? | Voluntary: Firm initiated |
Recall Number | D-1097-2022 |
Event ID | 89646 |
Brand | DEPO-MEDROL |
Generic Name | METHYLPREDNISOLONE ACETATE |
Manufacturer | METHYLPREDNISOLONE ACETATE |
Original Package? | 1 |
Active Substance | METHYLPREDNISOLONE ACETATE |
Drug Route | INTRA-ARTICULAR |
Distribution | USA nationwide. |
Quantity | 177 cartons |
Recall Reason | cGMP deviations: Temperature abuse |
Drug Classification | Class II |
Drug Code Info | 20220615 |
Product NDC | 0009-3073 0009-3475 |
Drug UPC | 0300093073036 |
Recall Initiation Date | 20220413 |
Report Date | 20220615 |
Classification Date | 20220609 |
Address | 9954 Maryland DriveDeep Run Iii Ste. 4000 Richmond, VA 23233 United States |
Recalling Firm | Mckesson Medical-Surgical Inc. Corporate Office |
Initial Notification | Letter |
Unique Ingredient Identifier | 43502P7F0P |
Drug Application Number | NDA011757 |
Structured Product Labeling (SPL ID) | b2eabec8-4fae-4441-b4dd-9a01b0f91c4a |
Structured Product Labeling (SPL Set ID) | 9a7b3837-e038-48bf-97e9-78ad463760dc |
Similar To |